Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012.

Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nuñez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G.

Cell Death Differ. 2012 Jan;19(1):107-20. doi: 10.1038/cdd.2011.96. Epub 2011 Jul 15. Review.

2.

Caspase substrates and cellular remodeling.

Crawford ED, Wells JA.

Annu Rev Biochem. 2011;80:1055-87. doi: 10.1146/annurev-biochem-061809-121639. Review.

PMID:
21456965
3.

Cutting edge: proteolytic inactivation of poly(ADP-ribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes.

Malireddi RK, Ippagunta S, Lamkanfi M, Kanneganti TD.

J Immunol. 2010 Sep 15;185(6):3127-30. doi: 10.4049/jimmunol.1001512. Epub 2010 Aug 16.

4.

The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.

Krishnakumar R, Kraus WL.

Mol Cell. 2010 Jul 9;39(1):8-24. doi: 10.1016/j.molcel.2010.06.017. Review.

5.

The substrate specificity profile of human granzyme A.

Van Damme P, Maurer-Stroh S, Hao H, Colaert N, Timmerman E, Eisenhaber F, Vandekerckhove J, Gevaert K.

Biol Chem. 2010 Aug;391(8):983-97. doi: 10.1515/BC.2010.096.

PMID:
20536382
6.

Structural and kinetic determinants of protease substrates.

Timmer JC, Zhu W, Pop C, Regan T, Snipas SJ, Eroshkin AM, Riedl SJ, Salvesen GS.

Nat Struct Mol Biol. 2009 Oct;16(10):1101-8. doi: 10.1038/nsmb.1668. Epub 2009 Sep 20.

7.

Global mapping of the topography and magnitude of proteolytic events in apoptosis.

Dix MM, Simon GM, Cravatt BF.

Cell. 2008 Aug 22;134(4):679-91. doi: 10.1016/j.cell.2008.06.038.

8.

Executioner caspase-3 and caspase-7 are functionally distinct proteases.

Walsh JG, Cullen SP, Sheridan C, Lüthi AU, Gerner C, Martin SJ.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12815-9. doi: 10.1073/pnas.0707715105. Epub 2008 Aug 22.

9.

Apoptosis: controlled demolition at the cellular level.

Taylor RC, Cullen SP, Martin SJ.

Nat Rev Mol Cell Biol. 2008 Mar;9(3):231-41. Review.

PMID:
18073771
10.

Phosphorylation-regulated cleavage of the reticulon protein Nogo-B by caspase-7 at a noncanonical recognition site.

Schweigreiter R, Stasyk T, Contarini I, Frauscher S, Oertle T, Klimaschewski L, Huber LA, Bandtlow CE.

Proteomics. 2007 Dec;7(24):4457-67.

PMID:
18072206
11.

Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.

McStay GP, Salvesen GS, Green DR.

Cell Death Differ. 2008 Feb;15(2):322-31. Epub 2007 Nov 2.

12.

Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation.

Young JE, Gouw L, Propp S, Sopher BL, Taylor J, Lin A, Hermel E, Logvinova A, Chen SF, Chen S, Bredesen DE, Truant R, Ptacek LJ, La Spada AR, Ellerby LM.

J Biol Chem. 2007 Oct 12;282(41):30150-60. Epub 2007 Jul 23.

13.

Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9.

Denault JB, Eckelman BP, Shin H, Pop C, Salvesen GS.

Biochem J. 2007 Jul 1;405(1):11-9.

14.

Engineered hybrid dimers: tracking the activation pathway of caspase-7.

Denault JB, Békés M, Scott FL, Sexton KM, Bogyo M, Salvesen GS.

Mol Cell. 2006 Aug;23(4):523-33.

15.

The protein structures that shape caspase activity, specificity, activation and inhibition.

Fuentes-Prior P, Salvesen GS.

Biochem J. 2004 Dec 1;384(Pt 2):201-32. Review.

16.

Human caspase-7 activity and regulation by its N-terminal peptide.

Denault JB, Salvesen GS.

J Biol Chem. 2003 Sep 5;278(36):34042-50. Epub 2003 Jun 24.

17.

Protease degradomics: a new challenge for proteomics.

López-Otín C, Overall CM.

Nat Rev Mol Cell Biol. 2002 Jul;3(7):509-19. Review. No abstract available.

PMID:
12094217
18.

Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling.

Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff K.

Mol Biol Cell. 2002 Mar;13(3):978-88.

19.

Removal of the pro-domain does not affect the conformation of the procaspase-3 dimer.

Pop C, Chen YR, Smith B, Bose K, Bobay B, Tripathy A, Franzen S, Clark AC.

Biochemistry. 2001 Nov 27;40(47):14224-35.

PMID:
11714276
20.

Mechanism-based inactivation of caspases by the apoptotic suppressor p35.

Riedl SJ, Renatus M, Snipas SJ, Salvesen GS.

Biochemistry. 2001 Nov 6;40(44):13274-80.

PMID:
11683637

Supplemental Content

Support Center